Healthy and COPD Participants to Evaluate the Efficacy and Safety of Inhaled TV46017

Study Title
Study in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017
Teva Identifier
TV46017-COPD-10046
ClinicalTrials.gov Identifier
NCT02315131
Study Status
Terminated
Trial Condition(s)
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
Drug: TV46017 | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
20 Years to 75 Years
Trial Duration
03/01/2015 - 08/01/2015
Phase
Phase 1

Study Type

Interventional